Researchers are examining ways to improve respiratory syncytial virus (RSV) prevention through immunization, including the use of maternal vaccines and monoclonal antibodies. Studies are investigating the efficacy and real-world effectiveness of RSV prophylaxis, as well as the impact of vaccination on different age groups. The american academy of pediatrics has updated its immunization schedule, which may differ from recommendations made by other health advisers.